New Era of ADME and Beyond (NE-ADME 2023)
June 21, 2023 at Novartis Institutes for BioMedical Research
250 Massachusetts Avenue, Cambridge 02139
Now Accepting Poster Submissions for NE-ADME 2023! (See Poster tab for more information)
2023 CONFIRMED SPEAKERS
![]() |
PLENARY SPEAKERBhagwat Prasad, PhDPrincipal Investigator, Associate Professor @ Washington State UniversityQuantitative Proteomics-Informed Modeling for Prediction of Drug Clearance and Drug Interactions |
![]() |
Seth Carbonneau, PhDPrincipal Investigator II @ NIBRTargeted Protein Degrader Applications for Gene Therapy and Small Molecule Drug Discovery |
![]() |
Ritu Singh, PhDAssociate Director, DMPK @ C4 Therapeutics, Inc.In vitro Binding Assays to Assess Exposure of Bifunctional Degradation Activating Compounds (BiDACs) in the Brain |
||
![]() |
Stephen Greene, PharmDAssociate Scientific Director, Clinical Pharmacology & Pharmacometrics @ ModernaModel-informed Drug Development (MIDD) in the mRNA-based Therapeutics & Vaccines |
![]() |
Michael Hayashi, BSScientist II @ Dicerna Pharmaceuticals, Inc.Use of HRMS and Novatia Software to Investigate siRNA In Vitro Uptake, Metabolic Stability, and Metabolite Identification in Primary Human Hepatocytes |
||
![]() |
Peng Hsiao, PhDDirector DMPK @ Ferring Research InstituteAntibacterial Efficacy of the Macrocyclic Depsipeptide Teixobactin in the Neutropenic Mouse PK-PD Model of Thigh Infection |
![]() |
Andrea Peier, PhDSenior Director, Cell Sciences @ MerckNanoClick Assay: A High Throughput, Target-agnostic Permeability Assay that Combines NanoBRET Technology with Intracellular Click Chemistry |
||
![]() |
Dan Wall, PhDAssociate Director @ NovartisBioanalysis for Radio Ligand Therapies (RLTs) with LCMS/MS & LC ICP MS |
![]() |
Hongbin Yu, PhDOncology Therapeutic Area Lead @ Boehringer Ingelheim PharmaPerspectives on ADME Studies of Therapeutic Proteins |
||
![]() |
Maciej Czerwiński, PhDDirector @ BioIVTRecommendations for Successful In Vitro Evaluation of Pharmacokinetic Drug Interaction Potential of ADC's |
![]() |
Seema Chauhan Kumar, PhDSenior Director DMPK @ Pioneering MedicinesPerspectives on DMPK Support for ADC's |
||
![]() |
Anup Zutshi, PhDSr. Scientific Director & Global Head Translational Pharmacology @ EMD SeronoTranslational Modeling for a First in Class MUC1xEGFR (M1231) Bispecific Antibody Drug Conjugate |
![]() |
Abdul Basit, PhDAssociate Director, Discovery Bioanalysis @ Solvo Biotechnology, a Charles River CompanyMultiplexing Oligonucleotide Analysis with Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) |